Methods for treating patients with catheter-based renal neuromodulation
US11553960B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2019 |
| Grant date | Jan 17, 2023 |
| Priority date | — |
| Expiry date | Apr 12, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36117
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods for treating hypertension and associated systems and methods are disclosed herein. One aspect of the present technology, for example, is directed to methods for therapeutic renal neuromodulation that partially inhibit sympathetic neural activity in renal nerves proximate a renal blood vessel of a human patient having a 24-hour heart rate at or above a median heart rate for a population of hypertensive patients. This reduction in sympathetic neural activity is expected to therapeutically treat one or more conditions associated with hypertension of the patient. Renal sympathetic nerve activity can be modulated, for example, using an intravascularly positioned catheter carrying a neuromodulation assembly, e.g., a neuromodulation assembly configured to use electrically-induced, thermally-induced, and/or chemically-induced approaches to modulate the renal nerves.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.